Summary
In an acute, double-blind, crossover study on 12 patients with essential hypertension, the interaction between nifedipine and prazosin was investigated in the supine position. The effectiveness of the combination of the two active drugs was greater than the combination of either of the drugs plus placebo. The effect of nifedipine was not modified by prazosin pretreatment; however, the effect of prazosin was partly inhibited, i.e., delayed, by nifedipine pretreatment. Therefore, giving prazosin as a first drug and nifedipine as the second drug seems to be a better approach than the reverse.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Braunwald E. Mechanism of action of calcium-channel-blocking agents.N Engl J Med 1982;307:1618–1627.
Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscle.Physiol Rev 1979;59:606–718.
Leonetti G, Cuspindi C, Sampieri L, Terzoli L, Zanchetti A. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.J Cardiovasc Pharmacol 1982;4 (Suppl):S319-S324.
Van Zwieten PA, Timmermans, PBMWM. Cardiovascular alpha2-receptors.J Mol Cell Cardiol 1983;15:713–733.
McGrath JC. Evidence for more than one type of postjunctional alpha-adrenoceptor.Biochem Pharmacol 1982; 31: 467–484.
Kiowski W, Hulthen UL, Ritz R, Bühler FL. Alpha2-adrenoceptor-mediated vasoconstriction of arteries.Clin Pharmacol Ther 1983;34:565–569.
Elliot HL, Reid JL. Evidence for postjunctional vascular alpha2-adrenoceptors in peripheral vascular regulation in man.Clin Sci 1983;65:237–241.
Van Zwieten PA, van Meel JCA, Timmermans PBM WM. Pharmacology of calcium entry blockers: Interaction with vascular alpha-adrenoceptors.Hypertension 1983;5(Suppl II): 8–17.
Saeed M, Holtz J, Elsner D, Bassenge E. Attenuation of sympathetic vasoconstriction by nifedipine: The role of vascular alpha2-adrenoceptors.Eur J Pharmacol 1983;94:149–153.
Jee LD, Opie LH. Acute hypotensive response to nifedipine added to prazosin in treatment of hypertension (letter).Br Med J 1983;287:1514.
Timmermans PBMWM, Thoolen MJMC, de Jonge A, Wilffert B, van Zwieten PA. Calcium entry and alpha-adrenoceptor-induced vasoconstriction in vivo and in vitro. In: Refsum H, Mjos OD, (eds.) Alpha-adrenoceptor blockers in Cardiovascular Disease. Churchill Livingstone, 1985:30–50.
Sluiter HE, Huysmans FTM, Thien TA, Koene RAP. The influence of alpha-adrenergic blockade on the acute antihypertensive effect of nifedipine.Eur J Clin Pharmacol 1985;29:263–267.
Pasanisi F, Elliott HL, Meredith PA, McSharry D, Reid JL. A pharmacodynamic and pharmacokinetic investigation of combined alpha adrenoceptor antagonism and calcium channel blockade in normal man.Clin Pharm Ther 1984;36:716–723.
Vincent J, Meredith PA, Reid JL, Elliott HL, Rubin PC. Clinical pharmacokinetics of prazosin—1985.Clin Pharmacokinetics 1985;10:144–154.
Pasanisi F, Elliott HL, Meredith PA, Sumner DJ, Reid JL. Effect of calcium channel blockers on adrenergic and noradrenergic vascular responses in man.J Cardiovasc Pharmacol 1985;7:1166–1170.
Vanhoutte PM. Calcium entry blockers and vascular smooth muscle.Circulation 1982;65:1–11.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kiss, I., Farsang, C. Nifedipine-prazosin interaction in patients with essential hypertension. Cardiovasc Drug Ther 3, 413–415 (1989). https://doi.org/10.1007/BF01858112
Issue Date:
DOI: https://doi.org/10.1007/BF01858112